中国卫生产业
中國衛生產業
중국위생산업
CHINA HEALTH INDUSTRY
2014年
22期
10-11
,共2页
腹膜透析%相关性腹膜炎%细菌感染
腹膜透析%相關性腹膜炎%細菌感染
복막투석%상관성복막염%세균감염
Peritoneal dialysis%Correlation peritonitis%Bacterial infections
目的：探讨腹膜透析并发腹膜炎的临床病因及防治措施。方法本组共39例腹膜透析并发腹膜炎患者，其中男性患者15例，女性患者24例，年龄在31~76岁之间，平均年龄为63岁。其中，慢性肾小球肾炎患者为22例，糖尿病肾病患者为12例，高血压肾损害3例，慢性间质性肾炎2例。结果本组39例患者当中，行腹透液培养，培养出细菌25例，阳性率达64.1%。其中革兰阳性球菌11例、革兰阴性杆菌13例、真菌1例。革兰阳性球菌中表皮葡萄球菌6例，金黄色葡萄球菌3例，屎肠球菌2例，革兰阴性杆菌中大肠埃希菌7例，肺炎克雷伯菌3例，鲍曼氏不动杆菌2例，阴沟肠杆菌1例，其中2例大肠埃希菌为多重耐药菌（EBLS+），屎肠球菌为多重耐药，其中治愈38例，拔管1例。结论有效地避免各种感染因素，对于预防腹膜炎的发生及其重要，头孢唑啉联合氨基糖苷类抗生素可作为首选方案。
目的：探討腹膜透析併髮腹膜炎的臨床病因及防治措施。方法本組共39例腹膜透析併髮腹膜炎患者，其中男性患者15例，女性患者24例，年齡在31~76歲之間，平均年齡為63歲。其中，慢性腎小毬腎炎患者為22例，糖尿病腎病患者為12例，高血壓腎損害3例，慢性間質性腎炎2例。結果本組39例患者噹中，行腹透液培養，培養齣細菌25例，暘性率達64.1%。其中革蘭暘性毬菌11例、革蘭陰性桿菌13例、真菌1例。革蘭暘性毬菌中錶皮葡萄毬菌6例，金黃色葡萄毬菌3例，屎腸毬菌2例，革蘭陰性桿菌中大腸埃希菌7例，肺炎剋雷伯菌3例，鮑曼氏不動桿菌2例，陰溝腸桿菌1例，其中2例大腸埃希菌為多重耐藥菌（EBLS+），屎腸毬菌為多重耐藥，其中治愈38例，拔管1例。結論有效地避免各種感染因素，對于預防腹膜炎的髮生及其重要，頭孢唑啉聯閤氨基糖苷類抗生素可作為首選方案。
목적：탐토복막투석병발복막염적림상병인급방치조시。방법본조공39례복막투석병발복막염환자，기중남성환자15례，녀성환자24례，년령재31~76세지간，평균년령위63세。기중，만성신소구신염환자위22례，당뇨병신병환자위12례，고혈압신손해3례，만성간질성신염2례。결과본조39례환자당중，행복투액배양，배양출세균25례，양성솔체64.1%。기중혁란양성구균11례、혁란음성간균13례、진균1례。혁란양성구균중표피포도구균6례，금황색포도구균3례，시장구균2례，혁란음성간균중대장애희균7례，폐염극뢰백균3례，포만씨불동간균2례，음구장간균1례，기중2례대장애희균위다중내약균（EBLS+），시장구균위다중내약，기중치유38례，발관1례。결론유효지피면각충감염인소，대우예방복막염적발생급기중요，두포서람연합안기당감류항생소가작위수선방안。
Objective To explore the clinical etiology and peritoneal dialysis with peritonitis prevention measures. Methods A total of 39 patients with peritoneal dialysis with peritonitis, of which 15 patients with male and female patients with 24 patients, aged between 31-76, the average age was 63 years old. Among them, in 22 patients with chronic glomerulonephritis, 12 patients with diabetic nephropathy, 3 cases of hypertensive renal impairment, chronic interstitial nephritis in 2 cases. Results Among 39 pa-tients, abdomen through liquid culture, cultivate bacteria 25 cases, positive rate was 64.1%. Of which 11 cases were gram positive coccus, gram negative bacillus in 13, fungi in 1 case. Gram positive coccus in 6 cases by staphylococcus epidermidis and staphy-lococcus aureus in 3, excrement enterococcus in 2 cases, gram negative bacilli in 7 cases of e. coli, klebsiella pneumoniae (3 cas-es), bowman's acinetobacter in 2 cases, sewer enterobacter in 1 case, 2 cases of e. coli for multiple drug-resistant bacteria (EBLS+), excrement enterococcus for multiple drug resistance, 38 cases were cured, 1 tube drawing. Conclusion Effectively avoid all kinds of infection factors, to prevent the happening of the peritonitis and its important, cefazolin joint aminoglycoside antibiotics can be used as the preferred solution..
